Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2020 Filed Dec 9, 2020 19:11 UTC |
BLAKE FRANCIS SDirector
|
GrantCommon Stock | 218 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030961 · form4.xml · nonDerivative · entry 1 BLAKE FRANCIS S · CIK 0001194702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,272.98 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 19:12 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030962 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,869.554 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 20:31 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030977 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,231.878 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 04, 2020 Filed Dec 17, 2020 22:21 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
GiftCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031831 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Indirect · Shailesh Jejurikar Trust Disclosed balance after: 10,243 Read SEC document |
| December 04, 2020 Filed May 11, 2021 17:26 UTC |
Coombe Gary ACEO - Grooming
|
GiftCommon Stock | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016179 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,011 Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 00:33 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 24,669 | $138.14 | $3,407,657.25 |
DisclosureSEC source: 0001209191-20-060805 · doc4.xml · nonDerivative · entry 2 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 9,818,367 F4 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $137.905 to $138.61. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd.,and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F3 · ownership.nature: (FN 2, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 00:33 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 281,898 | $137.24 | $38,688,470.83 |
DisclosureSEC source: 0001209191-20-060805 · doc4.xml · nonDerivative · entry 1 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 9,843,036 F1 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $136.91 to $137.90. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd.,and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F3 · ownership.nature: (FN 2, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 20:30 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
OtherSeries A Preferred Stock · Derivative | 5.024 | $139.18 | $699.22 |
DisclosureSEC source: 0001127602-20-029823 · form4.xml · derivative · entry 9 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse, By Retirement Plan Trustees Disclosed balance after: 0 Underlying: Common Stock · 5.024 shares Expires not disclosed F8 · derivative.exercise_price: $139.1769 F1 · kind: Preferred Stock converted to Common Stock at market price of Common Stock as part of discretionary disposition from employee benefits plan. F5 · derivative.exercise_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. F5 · derivative.expiration_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 20:30 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
OtherCommon Stock | 26.3359 | $139.18 | $3,665.35 |
DisclosureSEC source: 0001127602-20-029823 · form4.xml · nonDerivative · entry 2 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse, By Retirement Plan Trustees Disclosed balance after: 0 Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 20:30 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
OtherCommon Stock | 5.024 | $139.18 | $699.22 |
DisclosureSEC source: 0001127602-20-029823 · form4.xml · nonDerivative · entry 1 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse, By Retirement Plan Trustees Disclosed balance after: 26.3359 F1 · kind: Preferred Stock converted to Common Stock at market price of Common Stock as part of discretionary disposition from employee benefits plan. F2 · balance_after: Reflects adjustment to PST through September 30, 2020. Read SEC document |
| November 16, 2020 Filed Nov 23, 2020 20:30 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
GrantRestricted Stock Units · Derivative | 101.6596 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-029823 · form4.xml · derivative · entry 8 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,982.4056 Underlying: Common Stock · 101.6596 shares Expires not disclosed F6 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F7 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F7 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 14:36 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GrantRestricted Stock Units · Derivative | 14.4846 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031658 · form4.xml · derivative · entry 6 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14.4846 Underlying: Common Stock · 14.4846 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 18:57 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
GrantRestricted Stock Units · Derivative | 33.725 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · derivative · entry 9 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506.012 Underlying: Common Stock · 33.725 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 19:00 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 24.9398 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031738 · form4.xml · derivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270.9518 Underlying: Common Stock · 24.9398 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 19:03 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 5.9336 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031739 · form4.xml · derivative · entry 6 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18.2516 Underlying: Common Stock · 5.9336 shares Expires not disclosed F6 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F7 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F7 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 19:06 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
GrantRestricted Stock Units · Derivative | 118.5897 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031740 · form4.xml · derivative · entry 13 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,523.5327 Underlying: Common Stock · 118.5897 shares Expires not disclosed F6 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F7 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F7 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 22:02 UTC |
Bishop Steven DCEO - Health Care
|
GrantRestricted Stock Units · Derivative | 97.6476 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031809 · form4.xml · derivative · entry 7 Bishop Steven D · CIK 0001669212 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883.6546 Underlying: Common Stock · 97.6476 shares Expires not disclosed F7 · derivative.exercise_price: Dividend equivalents in the form of Retirement Restricted Stock Units (RSUs) previously awarded pursuant to Issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F8 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F8 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 22:02 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
GrantRestricted Stock Units · Derivative | 34.188 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031813 · form4.xml · derivative · entry 5 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534.387 Underlying: Common Stock · 34.188 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 22:06 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
GrantRestricted Stock Units · Derivative | 18.5342 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031823 · form4.xml · derivative · entry 7 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142.0322 Underlying: Common Stock · 18.5342 shares Expires not disclosed F6 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F7 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F7 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 22:14 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 149.0212 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031827 · form4.xml · derivative · entry 9 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,152.3732 Underlying: Common Stock · 149.0212 shares Expires not disclosed F6 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F7 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F7 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 22:16 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 66.5321 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031830 · form4.xml · derivative · entry 8 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,720.8641 Underlying: Common Stock · 66.5321 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 22:21 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 13.912 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031831 · form4.xml · derivative · entry 7 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118.486 Underlying: Common Stock · 13.912 shares Expires not disclosed F7 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F8 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F8 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 16, 2020 Filed May 11, 2021 17:26 UTC |
Coombe Gary ACEO - Grooming
|
GrantRestricted Stock Units · Derivative | 22.878 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016179 · form4.xml · derivative · entry 6 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345.24 Underlying: Common Stock · 22.878 shares Expires not disclosed F6 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F7 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F7 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 14:30 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-20-029045 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,202 Underlying: Common Stock · 30,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 14:30 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 30,000 | $144.26 | $4,327,857.00 |
DisclosureSEC source: 0001127602-20-029045 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,953.5414 F1 · price: Weighted average price of the shares sold. The price range was $144.23 to $144.36. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 14:30 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 30,000 | $85.13 | $2,553,900.00 |
DisclosureSEC source: 0001127602-20-029045 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,953.5414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Dec 17, 2020 18:57 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
GiftCommon Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,259.749 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 13:49 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,294 | $0.00 Strike: $79.05 | $0.00 |
DisclosureSEC source: 0001127602-20-028691 · form4.xml · derivative · entry 8 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,294 shares Expires 2023-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 13:49 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,219 | $0.00 Strike: $76.18 | $0.00 |
DisclosureSEC source: 0001127602-20-028691 · form4.xml · derivative · entry 7 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,219 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 13:49 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
SaleCommon Stock | 9,294 | $140.00 | $1,301,160.00 |
DisclosureSEC source: 0001127602-20-028691 · form4.xml · nonDerivative · entry 4 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,463.872 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 13:49 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
Exercise / conversionCommon Stock | 9,294 | $79.05 | $734,690.70 |
DisclosureSEC source: 0001127602-20-028691 · form4.xml · nonDerivative · entry 3 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,757.872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 13:49 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
SaleCommon Stock | 25,219 | $140.00 | $3,530,660.00 |
DisclosureSEC source: 0001127602-20-028691 · form4.xml · nonDerivative · entry 2 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,463.872 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 13:49 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
Exercise / conversionCommon Stock | 25,219 | $76.18 | $1,921,183.42 |
DisclosureSEC source: 0001127602-20-028691 · form4.xml · nonDerivative · entry 1 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,682.872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 14:53 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-20-028419 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,202 Underlying: Common Stock · 35,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 14:53 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 35,000 | $143.31 | $5,015,832.50 |
DisclosureSEC source: 0001127602-20-028419 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,953.5414 F1 · price: Weighted average price of the shares sold. The price range was $143.27 to $143.39. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 14:53 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 35,000 | $85.13 | $2,979,550.00 |
DisclosureSEC source: 0001127602-20-028419 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,953.5414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 15:39 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $83.87 | $0.00 |
DisclosureSEC source: 0001127602-20-028078 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 15:39 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 30,000 | $142.44 | $4,273,311.00 |
DisclosureSEC source: 0001127602-20-028078 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,953.5414 F1 · price: Weighted average price of the shares sold. The price range was $142.40 to $142.56. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 15:39 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 30,000 | $83.87 | $2,516,100.00 |
DisclosureSEC source: 0001127602-20-028078 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,953.5414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 15:42 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
SaleCommon Stock | 23,779 | $142.00 | $3,376,672.69 |
DisclosureSEC source: 0001127602-20-028081 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,385.839 F1 · price: Weighted average price of the shares sold. The price range was $142.00 to $142.05. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,371 | $0.00 Strike: $69.45 | $0.00 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · derivative · entry 10 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,371 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,496 | $0.00 Strike: $83.87 | $0.00 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · derivative · entry 9 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,496 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
SaleCommon Stock | 30,371 | $142.94 | $4,341,157.85 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 4 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,959.749 F1 · price: Weighted average price of the shares sold. The price range was $142.70 to $143.22. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionCommon Stock | 30,371 | $69.45 | $2,109,265.95 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,330.749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
SaleCommon Stock | 21,496 | $142.94 | $3,072,586.65 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,959.749 F1 · price: Weighted average price of the shares sold. The price range was $142.70 to $143.22. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
Exercise / conversionCommon Stock | 21,496 | $83.87 | $1,802,869.52 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,455.749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 11:29 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,054 | $0.00 Strike: $83.87 | $0.00 |
DisclosureSEC source: 0001127602-20-027548 · form4.xml · derivative · entry 5 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 35,054 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 11:29 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 35,054 | $142.67 | $5,001,031.49 |
DisclosureSEC source: 0001127602-20-027548 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,953.5414 F1 · price: Weighted average price of the shares sold. The price range was $142.62 to $142.77. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 11:29 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 35,054 | $83.87 | $2,939,978.98 |
DisclosureSEC source: 0001127602-20-027548 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,007.5414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2020 Filed Oct 26, 2020 14:46 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 95,170 | $0.00 Strike: $76.18 | $0.00 |
DisclosureSEC source: 0001127602-20-027475 · form4.xml · derivative · entry 5 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,170 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.